Google Ad

Zydus Cadila launches India’s most cost-effective remdesivir model at Rs 2,800 per 100 mg vial – Home Health Choices

BENGALURU: Zydus Cadila on Thursday launched the most affordable generic model of Gilead Sciences’ antiviral drug remdesivir in India to deal with COVID-19 following experiences of shortages at hospitals on the earth’s third-worst hit nation.

Zydus has priced it at Rs 2,800 per 100mg vial. It will likely be bought below the model title Remdac to authorities and personal hospitals treating COVID-19 sufferers, the corporate stated in a regulatory submitting.

Officials in some Indian states had a couple of weeks in the past complained of provide points, however a prime government at drugmaker Cipla Ltd had earlier this week stated the provides had been stabilising.

Zydus is the fifth firm to launch a replica of the antiviral in India after privately held Hetero Labs Ltd, Cipla, Mylan NV and Jubilant Life Sciences Ltd.

Gilead has additionally entered into licensing agreements with Dr.Reddy’s Laboratories Ltd and Syngene International Ltd to make remdesivir for distribution in 127 nations, together with India.

India has reported a every day bounce of greater than 50,000 coronavirus infections for 2 weeks, with complete circumstances as of Wednesday at 2.33 million.

Latest Updates

Related Post